参考文献/References:
[1] GBD 2013 Mortality and Causes of Death Collaborators. Global, regional, and national age- sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the global burden of disease study 2013[J]. Lancet, 2015, 385(9963): 117-171.
[2] Dichgans M. Genetics of ischaemic stroke[J]. Lancet Neurol, 2007, 6(2): 149-161.
[3] Guo JM, Liu AJ, Su DF. Genetics of stroke[J]. Acta Pharmacol Sin, 2010, 31(9): 1055-1064.
[4] Yi X, Lin J, Wang Y, et al. Association of cytochrome P450 genetic variants with clopidogrel resistance and outcomes in acute ischemic stroke[J]. J Atheroscler Thromb, 2016, 23(10): 1188-1200.
[5] Yi X, Wang Y, Lin J, et al. Interaction of CYP2C19, P2Y12, and GPIIIa variants associates with efficacy of clopidogrel and adverse events on patients with ischemic stroke[J]. Clin Appl Thromb Hemost, 2016, https:// doi.org/10.1177/1076029616648408.
[6] Calder PC. Polyunsaturated fatty acids and inflammatory processes: new twists in an old tale[J]. Biochimie, 2009, 91(6): 791-795.
[7] Ward NC, Croft KD, Blacker D, et al. Cytochrome P450 metabolites of arachidonic acid are elevated in stroke patients compared with healthy controls[J]. Clin Sci(Lond), 2011, 121(11): 501-507.
[8] Yi X, Liao D, Wu L, et al. CYP genetic variants, CYP metabolite levels, and symptomatic carotid stenosis in ischemic stroke patients[J]. J Atheroscler Thromb, 2016, 23(5): 621-631.
[9] Yi X, Wu L, Liao D, et al. Interactions among CYP2C8, EPHX2, and CYP4A11 variants and CYP plasma metabolite levels in ischemic stroke[J]. J Atheroscler Thromb, 2016, 23(11): 1286-1293.
[10] Ruggeri ZM. Platelets in atherothrombosis[J]. Nat Med, 2002, 8(11): 1227-1234.
[11] Storey RF. Biology and pharmacology of the platelet P2Y12 receptor[J]. Curr Pharm Des, 2006, 12: 1255-1259.
[12] Dorsam RT, Kunapuli SP. Central role of the P2Y12 receptor in platelet activation[J]. J Clin Invest, 2004, 113(3): 340-345.
[13] Floyd C, Ferro A.The platelet fibrinogen receptor:from megakaryocyte to the mortuary[C]//doi,2012:012007.
[14] Angiolillo DJ, Fernandez-Ortiz A, Bernardo E, et al. PlA polymorphism and platelet reactivity following clopidogrel loading dose in patients undergoing coronary stent implantation[J]. Blood Coagul Fibrinolysis, 2004, 15(1): 89-93.
[15] Li Q, Chen BL, Ozdemir V, et al. Frequency of genetic polymorphisms of COX1, GPIIIa and P2Y1 in a Chinese population and association with attenuated response to aspirin[J]. Pharmacogenomics, 2007, 8(6): 577-586.
[16] Culverhouse R, Suarez BK, Lin J, et al. A perspective on epistasis: limits of models displaying no main effect[J]. Am J Hum Genet, 2002, 70(2): 461-471.
[17] Lou XY, Chen GB, Yan L, et al. A generalized combinatorial approach for detecting gene-by-gene and gene-by-environment interactions with application to nicotine dependence[J]. Am J Hum Genet, 2007, 80(6): 1125-1137.
[18] Suh JW, Koo BK, Zhang SY, et al. Increased risk of atherothrombotic events associated with cytochrome P450 3A5 polymorphism in patients taking clopidogrel[J]. CMAJ, 2006, 174(12): 1715-1722.
[19] Simon T, Verstuyft C, Mary-Krause M, et al. Genetic determinants of response to clopidogrel and cardiovascular events[J]. N Engl J Med, 2009, 360(4): 363-375.
[20] Yi X, Zhang B, Wang C, et al. Genetic polymorphisms of ALOX5AP and CYP3A5 increase susceptibility to ischemic stroke and are associated with atherothrombotic events in stroke patients[J]. J Stroke Cerebrovasc Dis, 2015, 24(3): 521-529.
[21] Yamada Y, Metoki N, Yoshida H, et al. Genetic factors for ischemic and hemorrhagic stroke in Japanese individuals[J]. Stroke, 2008, 39(8): 2211-2218.
[22] Yi X, Zhang B, Wang C, et al. CYP2C8 rs17110453 and EPHX2 rs751141 two-locus interaction increases susceptibility to ischemic stroke[J]. Gene, 2015, 565(1): 85-89.
[23] Marciante KD, Totah RA, Heckbert SR, et al. Common variation in cytochrome P450 epoxygenase genes and the risk of incident nonfatal myocardial infarction and ischemic stroke[J]. Pharmacogenet Genomics, 2008, 18(6): 535-543.
[24] Li XQ, Ma N, Li XG, et al.Association of PON1,P2Y12 and COX1 with recurrent ischemic events in patients with extracranial or intracranial stenting[Z],2016:e0148891.
[25] Zee RY, Michaud SE, Diehl KA, et al. Purinergic receptor P2Y, G-protein coupled, 12 gene variants and risk of incident ischemic stroke, myocardial infarction, and venous thromboembolism[J]. Atherosclerosis, 2008, 197(2): 694-699.
[26] Floyd CN, Ellis BH, Ferro A.The PlA1/A2 polymorphism of glycoprotein IIIa as a risk factor for stroke:a systematic review and meta-analysis[Z],2014:27.
[27] Larsen BT, Gutterman DD, Hatoum O. Emerging role of epoxyeicosatrienoic acids in coronary vascular function[J]. Eur J Clin Invest, 2006, 36(5): 293-300.
[28] Han SW, Kim SH, Lee JY, et al. A new subtype classification of ischemic stroke based on treatment and etiologic mechanism[J]. Eur Neurol, 2007, 57(2): 96-102.
[29] Yi XY, Wang C, Liu P, et al. Antiplatelet drug resistance is associated with early neurological deterioration in acute minor ischemic stroke in the Chinese population[J]. J Neurol, 2016, 263(8): 1612-1619.
[30] Wang S, Zhao H. Sample size needed to detect gene-gene interactions using association designs[J]. Am J Epidemiol, 2003, 158(9): 899-914.
[31] He J, Wang MY, Qiu LX, et al. Genetic variations of mTORC1 genes and risk of gastric cancer in an eastern chinese population[J]. Mol Carcinog, 2013, 52(S1): E70-79.
相似文献/References:
[1]高敏,张亚琼,芮海杰,等.内蒙古地区蒙古族与汉族血浆同型半胱氨酸水平差异及分析[J].卒中与神经疾病杂志,2015,22(01):47.
[2]杨新林,李月春,李锐铭,等.脑血管储备功能的临床应用进展[J].卒中与神经疾病杂志,2015,22(01):50.
[3]王本孝.脑微出血的研究进展[J].卒中与神经疾病杂志,2015,22(01):52.
[4]曹阳月,朱雨岚.脑缺血后处理与PI3K/Akt信号转导通路的研究进展[J].卒中与神经疾病杂志,2015,22(03):192.
[5]冯庆琪,李昂,王巍.κ阿片受体激动剂(U50488H)对缺血性脑卒中大鼠神经元自噬、迟发性神经元损伤及NOTCH表达水平的影响[J].卒中与神经疾病杂志,2022,29(04):311.[doi:10.3969/j.issn.1007-0478.2022.04.002]
Feng Qingqi*,Li Ang*,Wang Wei.*.Effects of κ opioid receptor agonist(U50488H)on autophagy, delayed nerve injury and NOTCH expression in ischemic stroke rats[J].Stroke and Nervous Diseases,2022,29(04):311.[doi:10.3969/j.issn.1007-0478.2022.04.002]
[6]曹炳华,乔振虎.缺血性脑卒中患者血清SIRT1水平与早期神经功能恶化的相关性研究[J].卒中与神经疾病杂志,2022,29(04):330.[doi:10.3969/j.issn.1007-0478.2022.04.005]
Cao Binghua,Qiao Zhenhu..Correlation between serum SIRT1 and early neurological deterioration of patients with ischemic stroke[J].Stroke and Nervous Diseases,2022,29(04):330.[doi:10.3969/j.issn.1007-0478.2022.04.005]
[7]何涛,索志超,孔德强,等.术前血清CTRP3,CTRP9水平与缺血性脑卒中患者颈动脉支架成形术后再狭窄的相关性研究[J].卒中与神经疾病杂志,2022,29(05):427.[doi:10.3969/j.issn.1007-0478.2022.05.006]
e Tao*,Suo Zhichao,Kong Deqiang*,et al.Correlation between preoperative serum CTRP3, CTRP9 levels and restenosis after carotid artery stenting in patients with cerebral ischemic stroke[J].Stroke and Nervous Diseases,2022,29(04):427.[doi:10.3969/j.issn.1007-0478.2022.05.006]
[8]林夏妃,吴海霞,史静琴,等.呼吸肌训练经皮质-膈肌通路对缺血性脑卒中患者的作用机制分析[J].卒中与神经疾病杂志,2022,29(05):442.[doi:10.3969/j.issn.1007-0478.2022.05.009]
Lin Xiafei,Wu Haixia,Shi Jingqin,et al.Mechanism of respiratory muscle training via cortical diaphragm pathway in patients with ischemic stroke[J].Stroke and Nervous Diseases,2022,29(04):442.[doi:10.3969/j.issn.1007-0478.2022.05.009]
[9]宋秀威 杨月君 王伟.五味子乙素调节MAPK/NF-κB/AP-1信号通路对缺血性脑卒中大鼠神经元损伤的影响[J].卒中与神经疾病杂志,2023,30(03):242.[doi:10.3969/j.issn.1007-0478.2023.03.002]
Song Xiuwei*,Yang Yuejun,Wang Wei..Schisandrin B attenuates neuronal damage in rats with ischemic stroke by regulating MAPK/NF-κB/AP-1 signaling pathway[J].Stroke and Nervous Diseases,2023,30(04):242.[doi:10.3969/j.issn.1007-0478.2023.03.002]
[10]解晓睿,刘煜敏,和珂莉,等.中国人群脂联素+45位点基因单核苷酸多态性与缺血性脑卒中易感性的Meta分析[J].卒中与神经疾病杂志,2014,21(06):361.